The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer

por Brachova, Pavla, Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2013

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease

por Makki, Nader, Thiel, Kristina W., Miller, Francis J.
Publicado 2013

Past, present, and future of hormonal therapy in recurrent endometrial cancer

por Carlson, Matthew J, Thiel, Kristina W, Leslie, Kimberly K
Publicado 2014

The Dawning of the Age of Personalized Medicine in Gynecologic Oncology

por Leslie, Kimberly K., Thiel, Kristina W., Benbrook, Doris M., Mutch, David
Publicado 2020

Targeting Wnt Signaling in Endometrial Cancer

por Fatima, Iram, Barman, Susmita, Rai, Rajani, Thiel, Kristina W., Chandra, Vishal
Publicado 2021

An exploratory study of the variables impacting preterm birth rates in New Mexico

por Gwin, Kara M, Schrader, Ronald, Peters, Kimberley, Moreno, Armida, Thiel, Kristina W, Leslie, Kimberly K
Publicado 2012

Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment

por Meng, Xiangbing, Brachova, Pavla, Yang, Shujie, Xiong, Zhi, Zhang, Yuping, Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2011

Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53

por Meng, Xiangbing, Dizon, Don S., Yang, Shujie, Wang, Xinjun, Zhu, Danlin, Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2013

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer

por Kavlashvili, Tamar, Jia, Yichen, Dai, Donghai, Meng, Xiangbing, Thiel, Kristina W., Leslie, Kimberly K., Yang, Shujie
Publicado 2016

Role of metadherin in estrogen-regulated gene expression

por Li, Yujun, Bosquet, Jesus Gonzalez, Yang, Shujie, Thiel, Kristina W., Zhang, Yuping, Liu, Haitao, Leslie, Kimberly K., Meng, Xiangbing
Publicado 2017

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

por Bi, Jianling, Newtson, Andreea M., Zhang, Yuping, Devor, Eric J., Samuelson, Megan I., Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2021

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()

por Hovey, Adriann M., Devor, Eric J., Breheny, Patrick J., Mott, Sarah L., Dai, Donghai, Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2015

The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

por Leslie, Kimberly K., Thiel, Kristina W., Reyes, Henry D., Yang, Shujie, Zhang, Yuping, Carlson, Matthew J., Kumar, Nirmala S., Dai, Donghai D.
Publicado 2013

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

por Gonzalez-Bosquet, Jesus, Pedra-Nobre, Silvana, Devor, Eric J., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Leslie, Kimberly K.
Publicado 2021

Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer

por Bi, Jianling, Zhang, Yuping, Malmrose, Paige K., Losh, Haley A., Newtson, Andreea M., Devor, Eric J., Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2022

Prediction of chemo-response in serous ovarian cancer

por Gonzalez Bosquet, Jesus, Newtson, Andreea M., Chung, Rebecca K., Thiel, Kristina W., Ginader, Timothy, Goodheart, Michael J., Leslie, Kimberly K., Smith, Brian J.
Publicado 2016

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

por BRACHOVA, PAVLA, MUETING, SAMUEL R., CARLSON, MATTHEW J., GOODHEART, MICHAEL J., BUTTON, ANNA M., MOTT, SARAH L., DAI, DONGHAI, THIEL, KRISTINA W., DEVOR, ERIC J., LESLIE, KIMBERLY K.
Publicado 2014

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations

por Meng, Xiangbing, Yang, Shujie, Li, Yujun, Li, Yiyang, Devor, Eric J., Bi, Jianling, Wang, Xinhao, Umesalma, Shaikamjad, Quelle, Dawn E., Thiel, William H., Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2018

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

por Bi, Jianling, Dixit, Garima, Zhang, Yuping, Devor, Eric J., Losh, Haley A., Newtson, Andreea M., Coleman, Kristen L., Santillan, Donna A., Maretzky, Thorsten, Thiel, Kristina W., Leslie, Kimberly K.
Publicado 2021

Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers

por Thiel, Kristina W., Hernandez, Luiza I., Dassie, Justin P., Thiel, William H., Liu, Xiuying, Stockdale, Katie R., Rothman, Alissa M., Hernandez, Frank J., McNamara, James O., Giangrande, Paloma H.
Publicado 2012